Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct 1;4(11):bvaa144.
doi: 10.1210/jendso/bvaa144. eCollection 2020 Nov 1.

SARS-CoV-2 (COVID-19) and the Endocrine System

Michelle D Lundholm  1 , Caroline Poku  2 , Nicholas Emanuele  2   3 , Mary Ann Emanuele  2 , Norma Lopez  2
Affiliations
Review

SARS-CoV-2 (COVID-19) and the Endocrine System

Michelle D Lundholm et al. J Endocr Soc. .

Abstract

As SARS-CoV-2 (COVID-19) overtakes the world, causing moderate to severe disease in about 15% of infected patients, COVID-19 is also found to have widespread effects throughout the body with a myriad of clinical manifestations including the endocrine system. This manuscript reviews what is known about the impact of COVID-19 on the pathophysiology and management of diabetes (both outpatient and inpatient) as well as pituitary, adrenal, thyroid, bone, and gonadal function. Findings in this area are evolving, and long-term effects of infection remain an active area of further research.

Keywords: COVID-19; adrenal; diabetes mellitus; gonads; thyroid diseases.

PubMed Disclaimer

References

    1. Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. Published online September 10, 2019. doi:10.1016/j.diabres.2019.107843. - PubMed
    1. Garbati MA, Fagbo SF, Fang VJ, et al. A comparative study of clinical presentation and risk factors for adverse outcome in patients hospitalised with acute respiratory disease due to MERS coronavirus or other causes. PLoS One. 2016;11(11):e0165978. Published online November 3, 2016. doi:10.1371/journal.pone.0165978. - PMC - PubMed
    1. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289(21):2801-2809. - PubMed
    1. Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis. 2016;49:129-133. - PMC - PubMed
    1. Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020;14(4):303-310. - PMC - PubMed

LinkOut - more resources